Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KMgCit for Metabolic Side Effects of Chlorthalidone
NCT02665117Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2015
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of potassium citrate + magnesium citrate in hypertension (HTN) (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Change in Fasting Plasma Glucose at 16 weeks. Started Jan 2015; status: completed.
02
Drugs
potassium citrate + magnesium citrate
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02665117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02665117.